Login / Signup

Antiphospholipid Antibodies and Lipids in Hematological Malignancies.

Sonia Guadalupe Barreno-RochaSandra Guzmán-SilahuaSinaí-Del-Carmen Rodríguez-DávilaGuadalupe Estela Gavilanez-ChávezErnesto Germán Cardona-MuñozCarlos Riebeling-NavarroBenjamín Rubio-JuradoArnulfo Hernan Nava-Zavala
Published in: International journal of molecular sciences (2022)
One of the main groups of lipids is phospholipids, which are mainly involved in forming cell membranes. Neoplastic processes such as cell replication have increased lipid synthesis, making tumor cells dependent on this synthesis to maintain their requirements. Antiphospholipid antibodies attack phospholipids in the cell membranes. Three main types of antiphospholipid antibodies are recognized: anti-β2 glycoprotein I (anti-β2GP-I), anticardiolipin (aCL), and lupus anticoagulant (LA). These types of antibodies have been proven to be present in hematological neoplasms, particularly in LH and NHL. This review on antiphospholipid antibodies in hematological neoplasms describes their clinical relationship as future implications at the prognostic level for survival and even treatment.
Keyphrases
  • systemic lupus erythematosus
  • single cell
  • fatty acid
  • cell therapy
  • disease activity
  • atrial fibrillation
  • venous thromboembolism
  • current status
  • smoking cessation